PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biology, Southern University of Science and Technology, Shenzhen, Guangdong, 518055, China.\', \'School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, 518055, China.\', \'School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Hong Kong SAR, China.\', \'Department of Obstetrics and Gynecology, Shenzhen University General Hospital, Shenzhen, Guangdong, 518055, China.\', \'Clinical Medical Academy, Shenzhen University, Shenzhen, Guangdong, 518055, China.\', \'Department of Cardiology, Shenzhen University General Hospital, Shenzhen, Guangdong, 518055, China.\', \'Department of Obstetrics and Gynecology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China.\', \'School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, 518055, China. zhangjian@sustech.edu.cn.\', \'Department of Biology, Southern University of Science and Technology, Shenzhen, Guangdong, 518055, China. wanggy@sustech.edu.cn.\', \'Guangdong Provincial Key Laboratory of Computational Science and Material Design, Shenzhen, Guangdong, 518055, China. wanggy@sustech.edu.cn.\', \'Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research, Shenzhen, Guangdong, 518055, China. wanggy@sustech.edu.cn.\', \'Clinical Medical Academy, Shenzhen University, Shenzhen, Guangdong, 518055, China. lihaiying111@hotmail.com.\', \'Department of Cardiology, Shenzhen University General Hospital, Shenzhen, Guangdong, 518055, China. lihaiying111@hotmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s11655-020-3427-6
?:doi
?:hasPublicationType
?:journal
  • Chinese journal of integrative medicine
is ?:pmid of
?:pmid
?:pmid
  • 32740825
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.386
?:rankingScore_hIndex
  • 26
is ?:relation_isRelatedTo_publication of
?:title
  • In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32740825>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32740825>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all